Cytocast is a Hungarian company that revolutionizes drug discovery and personalized treatment by integrating bioinformatics databases with our cell simulator to predict how drugs and diseases modify cellular health.

In order to achieve this goal we set precise milestones for the next 5 years.

To sustain the cost of our business until full commercialization of our product we are going to open an investment round in the next few months. We are currently seeking a pre-seed investment of 250,000 € and a larger 1.25 million € seed round investment.
If you are interested to be part of our next funding round, get in touch with us.